Jacek Kwiecinski1, Evangelos Tzolos2, Alexander J Fletcher3, Jennifer Nash3, Mohammed N Meah3, Sebastien Cadet4, Philip D Adamson3, Kajetan Grodecki5, Nikhil Joshi3, Michelle C Williams3, Edwin J R van Beek6, Chi Lai7, Adriana A S Tavares3, Mark G MacAskill3, Damini Dey5, Andrew H Baker3, Jonathon Leipsic7, Daniel S Berman8, Stephanie L Sellers7, David E Newby6, Marc R Dweck3, Piotr J Slomka9. 1. Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland. 2. Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, California, USA; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. 3. BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. 4. Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA. 5. Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA. 6. BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom. 7. Department of Radiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada. 8. Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, California, USA. 9. Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA. Electronic address: piotr.slomka@cshs.org.
Abstract
OBJECTIVES: The aim of this study was to describe the potential of 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) to identify graft vasculopathy and to investigate the influence of coronary artery bypass graft (CABG) surgery on native coronary artery disease activity and progression. BACKGROUND: As well as developing graft vasculopathy, CABGs have been proposed to accelerate native coronary atherosclerosis. METHODS: Patients with established coronary artery disease underwent baseline 18F-NaF PET, coronary artery calcium scoring, coronary computed tomographic angiography, and 1-year repeat coronary artery calcium scoring. Whole-vessel coronary microcalcification activity (CMA) on 18F-NaF PET and change in calcium scores were quantified in patients with and without CABG surgery. RESULTS: Among 293 participants (mean age 65 ± 9 years, 84% men), 48 (16%) underwent CABG surgery 2.7 years [IQR: 1.4-10.4 years] previously. Although all arterial and the majority (120 of 128 [94%]) of vein grafts showed no 18F-NaF uptake, 8 saphenous vein grafts in 7 subjects had detectable CMA. Bypassed native coronary arteries had 3 times higher CMA values (2.1 [IQR: 0.4-7.5] vs 0.6 [IQR: 0-2.7]; P < 0.001) and greater progression of 1-year calcium scores (118 Agatston unit [IQR: 48-194 Agatston unit] vs 69 [IQR: 21-142 Agatston unit]; P = 0.01) compared with patients who had not undergone CABG, an effect confined largely to native coronary plaques proximal to the graft anastomosis. In sensitivity analysis, bypassed native coronary arteries had higher CMA (2.0 [IQR: 0.4-7.5] vs 0.8 [IQR: 0.3-3.2]; P < 0.001) and faster disease progression (24% [IQR: 16%-43%] vs 8% [IQR: 0%-24%]; P = 0.002) than matched patients (n = 48) with comparable burdens of coronary artery disease and cardiovascular comorbidities in the absence of bypass grafting. CONCLUSIONS: Native coronary arteries that have been bypassed demonstrate increased disease activity and more rapid disease progression than nonbypassed arteries, an observation that appears independent of baseline atherosclerotic plaque burden. Microcalcification activity is not a dominant feature of graft vasculopathy.
OBJECTIVES: The aim of this study was to describe the potential of 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) to identify graft vasculopathy and to investigate the influence of coronary artery bypass graft (CABG) surgery on native coronary artery disease activity and progression. BACKGROUND: As well as developing graft vasculopathy, CABGs have been proposed to accelerate native coronary atherosclerosis. METHODS: Patients with established coronary artery disease underwent baseline 18F-NaF PET, coronary artery calcium scoring, coronary computed tomographic angiography, and 1-year repeat coronary artery calcium scoring. Whole-vessel coronary microcalcification activity (CMA) on 18F-NaF PET and change in calcium scores were quantified in patients with and without CABG surgery. RESULTS: Among 293 participants (mean age 65 ± 9 years, 84% men), 48 (16%) underwent CABG surgery 2.7 years [IQR: 1.4-10.4 years] previously. Although all arterial and the majority (120 of 128 [94%]) of vein grafts showed no 18F-NaF uptake, 8 saphenous vein grafts in 7 subjects had detectable CMA. Bypassed native coronary arteries had 3 times higher CMA values (2.1 [IQR: 0.4-7.5] vs 0.6 [IQR: 0-2.7]; P < 0.001) and greater progression of 1-year calcium scores (118 Agatston unit [IQR: 48-194 Agatston unit] vs 69 [IQR: 21-142 Agatston unit]; P = 0.01) compared with patients who had not undergone CABG, an effect confined largely to native coronary plaques proximal to the graft anastomosis. In sensitivity analysis, bypassed native coronary arteries had higher CMA (2.0 [IQR: 0.4-7.5] vs 0.8 [IQR: 0.3-3.2]; P < 0.001) and faster disease progression (24% [IQR: 16%-43%] vs 8% [IQR: 0%-24%]; P = 0.002) than matched patients (n = 48) with comparable burdens of coronary artery disease and cardiovascular comorbidities in the absence of bypass grafting. CONCLUSIONS: Native coronary arteries that have been bypassed demonstrate increased disease activity and more rapid disease progression than nonbypassed arteries, an observation that appears independent of baseline atherosclerotic plaque burden. Microcalcification activity is not a dominant feature of graft vasculopathy.
Authors: Mikaela L McKenney-Drake; Paul R Territo; Ali Salavati; Sina Houshmand; Scott Persohn; Yun Liang; Mouhamad Alloosh; Sharon M Moe; Connie M Weaver; Abass Alavi; Michael Sturek Journal: JACC Cardiovasc Imaging Date: 2015-07-15
Authors: Arnav Kumar; Elizabeth W Thompson; Adrien Lefieux; David S Molony; Emily L Davis; Nikita Chand; Stephane Fournier; Hee Su Lee; Jon Suh; Kimi Sato; Yi-An Ko; Daniel Molloy; Karthic Chandran; Hossein Hosseini; Sonu Gupta; Anastasios Milkas; Bill Gogas; Hyuk-Jae Chang; James K Min; William F Fearon; Alessandro Veneziani; Don P Giddens; Spencer B King; Bernard De Bruyne; Habib Samady Journal: J Am Coll Cardiol Date: 2018-10-16 Impact factor: 24.094
Authors: Mathieu Rubeaux; Nikhil V Joshi; Marc R Dweck; Alison Fletcher; Manish Motwani; Louise E Thomson; Guido Germano; Damini Dey; Debiao Li; Daniel S Berman; David E Newby; Piotr J Slomka Journal: J Nucl Med Date: 2015-10-15 Impact factor: 10.057
Authors: Rachael O Forsythe; Marc R Dweck; Olivia M B McBride; Alex T Vesey; Scott I Semple; Anoop S V Shah; Philip D Adamson; William A Wallace; Jakub Kaczynski; Weiyang Ho; Edwin J R van Beek; Calum D Gray; Alison Fletcher; Christophe Lucatelli; Aleksander Marin; Paul Burns; Andrew Tambyraja; Roderick T A Chalmers; Graeme Weir; Neil Mitchard; Adriana Tavares; Jennifer M J Robson; David E Newby Journal: J Am Coll Cardiol Date: 2018-02-06 Impact factor: 24.094
Authors: Martin Lyngby Lassen; Jacek Kwiecinski; Damini Dey; Sebastien Cadet; Guido Germano; Daniel S Berman; Philip D Adamson; Alastair J Moss; Marc R Dweck; David E Newby; Piotr J Slomka Journal: Eur J Nucl Med Mol Imaging Date: 2019-08-05 Impact factor: 9.236
Authors: Nikhil V Joshi; Alex T Vesey; Michelle C Williams; Anoop S V Shah; Patrick A Calvert; Felicity H M Craighead; Su Ern Yeoh; William Wallace; Donald Salter; Alison M Fletcher; Edwin J R van Beek; Andrew D Flapan; Neal G Uren; Miles W H Behan; Nicholas L M Cruden; Nicholas L Mills; Keith A A Fox; James H F Rudd; Marc R Dweck; David E Newby Journal: Lancet Date: 2013-11-11 Impact factor: 79.321
Authors: Alastair J Moss; Alisia M Sim; Philip D Adamson; Michael A Seidman; Jack P M Andrews; Mhairi K Doris; Anoop S V Shah; Ralph BouHaidar; Carlos J Alcaide-Corral; Michelle C Williams; Jonathon A Leipsic; Marc R Dweck; Vicky E MacRae; David E Newby; Adriana A S Tavares; Stephanie L Sellers Journal: Sci Rep Date: 2020-11-19 Impact factor: 4.996